Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+8.92%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$26.5B
AUM Growth
+$3.48B
(+15%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
4.77%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,543
New
396
Increased
301
Reduced
281
Closed
335
Top Buys
| 1 |
Salesforce
CRM
|
+$444M |
| 2 |
Meta Platforms (Facebook)
META
|
+$327M |
| 3 |
Broadcom
AVGO
|
+$281M |
| 4 |
Amazon
AMZN
|
+$270M |
| 5 |
Uber
UBER
|
+$241M |
Top Sells
| 1 |
T-Mobile US
TMUS
|
+$270M |
| 2 |
Palo Alto Networks
PANW
|
+$232M |
| 3 |
AstraZeneca
AZN
|
+$222M |
| 4 |
Ross Stores
ROST
|
+$201M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$173M |
Sector Composition
| 1 | Healthcare | 21.16% |
| 2 | Technology | 20.34% |
| 3 | Consumer Discretionary | 12.14% |
| 4 | Industrials | 8.84% |
| 5 | Financials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VINC
826
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $352K | ﹤0.01% |
17,241
| – | – |
|
827
John B. Sanfilippo & Son
JBSS
$736M
| $350K | ﹤0.01% |
+4,300
| New | +$350K |
|
|
ARVL
828
DELISTED
Arrival Ordinary Shares
ARVL
| $348K | ﹤0.01% |
43,600
-8,012
| -16% | -$63.9K |
|
829
Sweetgreen
SG
$1.03B
| $315K | ﹤0.01% |
36,700
-84,706
| -70% | -$726K |
|
830
Talkspace, Inc. Warrant
TALKW
$2.52M
| $314K | ﹤0.01% |
4,313,000
| – | – |
|
831
Pagaya Technologies
PGY
$2.89B
| $310K | ﹤0.01% |
+20,833
| New | +$310K |
|
832
Stewart Information Services
STC
$2.05B
| $303K | ﹤0.01% |
7,100
+5,200
| +274% | +$222K |
|
833
Blue Owl Capital
OBDC
$7.25B
| $289K | ﹤0.01% |
25,000
| – | – |
|
834
BJ's Restaurants
BJRI
$726M
| $282K | ﹤0.01% |
10,700
-253,557
| -96% | -$6.69M |
|
835
ArcelorMittal
MT
$25.7B
| $274K | ﹤0.01% |
10,445
-8,529
| -45% | -$224K |
|
836
Stoke Therapeutics
STOK
$1.21B
| $265K | ﹤0.01% |
+28,700
| New | +$265K |
|
837
VF Corp
VFC
$5.95B
| $265K | ﹤0.01% |
+9,589
| New | +$265K |
|
|
AEVA
838
Aeva Technologies
AEVA
$826M
| $258K | ﹤0.01% |
37,920
-40,940
| -52% | -$278K |
|
839
3D Systems Corporation
DDD
$269M
| $248K | ﹤0.01% |
+33,500
| New | +$248K |
|
840
Nkarta
NKTX
$147M
| $248K | ﹤0.01% |
+41,346
| New | +$248K |
|
|
CNTA
841
Centessa Pharmaceuticals
CNTA
$2.8B
| $247K | ﹤0.01% |
79,700
-38,100
| -32% | -$118K |
|
842
GH Research
GHRS
$832M
| $239K | ﹤0.01% |
24,600
-178,000
| -88% | -$1.73M |
|
843
Praxis Precision Medicines
PRAX
$843M
| $238K | ﹤0.01% |
6,667
| – | – |
|
|
NBSE
844
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $238K | ﹤0.01% |
62,500
| – | – |
|
|
ETWO
845
DELISTED
E2open Parent Holdings
ETWO
| $235K | ﹤0.01% |
+40,000
| New | +$235K |
|
846
Ford
F
$45.7B
| $226K | ﹤0.01% |
+19,391
| New | +$226K |
|
847
Upstart Holdings
UPST
$6.63B
| $223K | ﹤0.01% |
+16,889
| New | +$223K |
|
848
Huntington Bancshares
HBAN
$25.7B
| $215K | ﹤0.01% |
+15,256
| New | +$215K |
|
849
Foghorn Therapeutics
FHTX
$307M
| $211K | ﹤0.01% |
33,000
-355,600
| -92% | -$2.27M |
|
850
Andersons Inc
ANDE
$1.37B
| $210K | ﹤0.01% |
6,000
+1,000
| +20% | +$35K |
|